The Case for MRI

  • Giovanni Morana
  • Raffaella Pozzi Mucelli
  • Giuseppe Granieri
  • Christian Cugini
Part of the Medical Radiology book series (MEDRAD)


Recently MRI has gained an increased importance in the evaluation of pancreatic pathology and especially pancreatic tumors thanks to its capacity for noninvasively exploring the pancreatic parenchyma, ducts and vascular structures.

The past limits due to movements artifacts, high acquisition time for T2w sequences and poor quality dynamic imaging are now swept away by several innovations, as rapid sequences, respiratory trigger compensation, fast high resolution sequences for dynamic imaging with contrast agent, 2D or 3D cholangio-pancreatography sequences with or without the use of secretin.

State of the art MRI equipment with high field magnets, powerful and fast gradients, phased-array surface coils and dedicated sequences provides detailed information about a suspicious pancreatic mass, differentiating it from benign conditions. MR-cholangiopancreatography sequence, with or without secretin, delineates its relations with the main pancreatic duct and the biliary tree, as well as the dynamic findings after secretin injection, useful in the differential diagnosis between benign and malignant strictures. Dynamic imaging with contrast agent allows staging of the tumor and, similarly to CT, determines if it is resectable or not.

In this chapter these aspects will be extensively analyzed to provide a valid help to understand all the issues of this pathology and to obtain all the information, fundamental for the surgeon and the patient, from a complex examination as MRI seems to be.


Pancreatic Cancer Chronic Pancreatitis Diffusion Weight Image Pancreatic Carcinoma Main Pancreatic Duct 


  1. Akisik MF, Sandrasegaran K, Aisen AA, Maglinte DD, Sherman S, Lehman GA (2006) Dynamic secretin-enhanced MR cholangiopancreatography. Radiographics 26:665–677PubMedCrossRefGoogle Scholar
  2. Akisik MF, Aisen AM, Sandrasegaran K, Jennings SG, Lin C, Sherman S, Lin JA, Rydberg M (2009) Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology 250:103–109PubMedCrossRefGoogle Scholar
  3. Albaraz R et al. (2009) Autoimmune pancreatitis: MR features before and after steroid therapy. E-Poster P-281 EPOSTM Online, System; ESGARGoogle Scholar
  4. Arai K, Kawai K, Kohda W, Tatsu H, Matsui O, Nakahama T (2003) Dynamic CT of acute cholangitis; early inhomogeneous enhancement of the liver. AJR AM J Roentgenol 181:115–118PubMedCrossRefGoogle Scholar
  5. Arslan A, Buanes T, Geitung JT (2001) Pancreatic carcinoma: MR, MR angiography and dynamic helical CT in the evaluation of vascular invasion. Eur J Radiol 38:151–159PubMedCrossRefGoogle Scholar
  6. Balci NC, Semelka RC (2001) Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma. Eur J Rad 38:105–112CrossRefGoogle Scholar
  7. Birchard KR, Semelka RC, Hyslop WB, Brown A, Armao D, Firat Z, Vaidean G (2005) Suspected pancreatic cancer: evaluation by dynamic gadolinium-enhanced 3D gradient-echo MRI. AJR Am J Roentgenol 185:700–703PubMedCrossRefGoogle Scholar
  8. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 11(346):1128–1137CrossRefGoogle Scholar
  9. Blasbalg R, Baroni RH, Costa DN, Machado MC (2007) MRI features of groove pancreatitis. AJR Am J Roentgenol 189:73–80PubMedCrossRefGoogle Scholar
  10. Braithwaite AC, Dale BM, Boll DT, Merkle EM (2009) Short- and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology 250:459–465PubMedCrossRefGoogle Scholar
  11. Brennan DD, Zamboni GA, Raptopoulos VD, Kruskal JB (2007) Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT. Radiographics 27:1653–1666PubMedCrossRefGoogle Scholar
  12. Bruegel M, Rummeny EJ (2010) Hepatic metastases: use of diffusion-weighted echo-planar imaging. Abdom Imaging 35: 454–61Google Scholar
  13. Castell-Monsalve FJ, Sousa-Martin JM, Carranza-Carranza A (2008) Groove pancreatitis: MRI and pathologic findings. Abdom Imaging 33:342–348PubMedCrossRefGoogle Scholar
  14. Colagrande S, Belli G, Politi LS, Mannelli L, Pasquinelli F, Villari N (2008) The influence of diffusion- and relaxation-related factors on signal intensity: an introductive guide to magnetic resonance diffusion-weighted imaging studies. J Comput Assist Tomogr 32:463–474PubMedCrossRefGoogle Scholar
  15. Cooperman AM, Kini S, Snady H, Bruckner H, Chamberlain RS (2000) Current surgical therapy for carcinoma of the pancreas. J Clin Gastroenterol 31:107–113PubMedCrossRefGoogle Scholar
  16. Danet IM, Semelka RC, Nagase LL, Woosely JT, Leonardou P, Armao D (2003) Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics. J Magn Reson Imaging 18:181–188PubMedCrossRefGoogle Scholar
  17. Doi R, Kami K, Ito D, Fujimoto K, Kawaguchi Y, Wada M, Kogire M, Hosotani R, Imamura M, Uemoto S (2007) Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer. World J Surg 31:147–154PubMedCrossRefGoogle Scholar
  18. Douglass HJ, Kim S, Meropol N (1997) Neoplasms of the exocrine pancreas. In: Holland J, Frei EI, Bast RJ, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer medicine, 4th edn. Williams & Wilkins, Baltimore, pp 1989–2018Google Scholar
  19. Fattahi R, Balci NC, Perman WH, Hsueh EC, Alkaade S, Havlioglu N, Burton FR (2009) Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging 29:350–356PubMedCrossRefGoogle Scholar
  20. Fukukura Y, Fujiyoshi F, Sasaki M, Nakajo M (2002) Pancreatic duct: morphologic evaluation with MR cholangiopancreatography after secretin stimulation. Radiology 222:674–680PubMedCrossRefGoogle Scholar
  21. Gabata T, Matsui O, Terayama N, Kobayashi S, Sanada J (2008) Imaging diagnosis of hepatic metastases of pancreatic carcinomas: significance of transient wedge-shaped contrast enhancement mimicking arterioportal shunt. Abdom Imaging 33:437–443PubMedCrossRefGoogle Scholar
  22. Greene FL, Page DL, Fleming ID et al (2002) Exocrine pancreas. In: Greene FL, Page DL, Fleming ID et al (eds) AJCC cancer staging manual, vol 6. Springer, New York, pp 157–164CrossRefGoogle Scholar
  23. Grenacher L, Klauss M, Dukic L, Delorme S, Knaebel HP, Dux M, Kauczor HU, Buchler MW, Kauffmann GW, Richter GM (2004) Diagnosis and staging of pancreatic carcinoma: MRI versus MSCT – a prospective study. Rofo 176:1624–1633PubMedCrossRefGoogle Scholar
  24. Hakimé A, Giraud M, Vullierme MP, Vilgrain V (2007) MR imaging of the pancreas. J Radiol 88:11–25PubMedCrossRefGoogle Scholar
  25. Hata H, Mori H, Matsumoto S, Yamada Y, Kiyosue H, Tanoue S, Hongo N, Kashima K (2010). Fibrous stroma and vascularity of pancreatic carcinoma: correlation with enhancement patterns on CT. Abdom Imaging. 35:172–80PubMedCrossRefGoogle Scholar
  26. Hellerhoff KJ, Helmberger H 3rd, Rösch T, Settles MR, Link TM, Rummeny EJ (2002) Dynamic MR pancreatography after secretin administration: image quality and diagnostic accuracy. AJR Am J Roentgenol 179:121–129PubMedCrossRefGoogle Scholar
  27. Hommeyer SC, Freeny PC, Crabo LG (1995) Carcinoma of the head of the pancreas: evaluation of the pancreaticoduodenal veins with dynamic CT–potential for improved accuracy in staging. Radiology 196:233–238PubMedGoogle Scholar
  28. Hough TJ, Raptopoulos V, Siewert B, Matthews JB (1999) Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas. AJR Am J Roentgenol 173:1509–1512PubMedCrossRefGoogle Scholar
  29. Ichikawa T, Sou H, Araki T, Arbab AS, Yoshikawa T, Ishigame K, Haradome H, Hachiya J (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116PubMedCrossRefGoogle Scholar
  30. Isaji S, Kawarada Y, Uemoto S (2004) Classification of pancreatic cancer: comparison of Japanese and UICC classifications. Pancreas 28:231–234PubMedCrossRefGoogle Scholar
  31. Johnson PT, Outwater EK (1999). Pancreatic carcinoma versus chronic pancreatitis: dynamic MR imaging. Radiology. 212: 213-8CrossRefGoogle Scholar
  32. Jones EC, Chezmar JL, Nelson RC, Bernardino ME (1992) The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. AJR Am J Roentgenol 158:535–539PubMedCrossRefGoogle Scholar
  33. Kanematsu M, Shiratori Y, Hoshi H, Kondo H, Matsuo M, Moriwaki H (2000) Pancreas and peripancreatic vessels: effect of imaging delay on gadolinium enhancement at dynamic gradient-recalled-echo MR Imaging. Radiology 215:95–102PubMedCrossRefGoogle Scholar
  34. Kartalis N, Lindholm TL, Aspelin P, Permert J, Albiin N (2009) Diffusion-weighted magnetic resonance imaging of pancreas tumours. Eur Radiol 19:1981–1990PubMedCrossRefGoogle Scholar
  35. Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N (1991) Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 22:387–395PubMedCrossRefGoogle Scholar
  36. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Ueno K, Tajima H, Elnemr A, Miwa K (1999) Analysis of Paraaortic Lymph Node Involvement in Pancreatic Carcinoma. A Significant Indication for Surgery? Cancer 85:583–590PubMedCrossRefGoogle Scholar
  37. Kim JH, Kim MJ, Chung JJ, Lee WJ, Yoo HS, Lee JT (2002) Differential diagnosis of periampullary carcinomas at MR imaging. Radiographics 22:1335–1352PubMedCrossRefGoogle Scholar
  38. Klöppel G (2007) Chronic pancreatitis, pseudotumors and other tumor-like lesions. Mod Pathol 20(Suppl 1):S113–S131PubMedCrossRefGoogle Scholar
  39. Kuroiwa T, Suda T, Takahashi T, Hirono H, Natsui M, Motoyama H, Nomoto M, Aoyagi Y (2002) Bile duct involvement in a case of autoimmune pancreatitis successfully treated with an oral steroid. Dig Dis Sci 47:1810–1816PubMedCrossRefGoogle Scholar
  40. Lee SS, Byun JH, Park BJ, Park SH, Kim N, Park B, Kim JK, Lee MG (2008). Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging. 28: 928–36PubMedCrossRefGoogle Scholar
  41. Lepanto L, Arzoumanian Y, Gianfelice D, Perreault P, Dagenais M, Lapointe R, Létourneau R, Roy A (2002) Helical CT with CT angiography in assessing periampullary neoplasms: identification of vascular invasion. Radiology 222:347–352PubMedCrossRefGoogle Scholar
  42. Liu RC, Traverso LW (2005) Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc 19:638–642PubMedCrossRefGoogle Scholar
  43. Lopez Hänninen E, Amthauer H, Hosten N, Ricke J, Böhmig M, Langrehr J, Hintze R, Neuhaus P, Wiedenmann B, Rosewicz S, Felix R (2002) Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology 224:34–41PubMedCrossRefGoogle Scholar
  44. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol 168:1439–1443PubMedCrossRefGoogle Scholar
  45. Maithel SK, Khalili K, Dixon E, Guindi M, Callery MP, Cattral MS, Taylor BR, Gallinger S, Greig PD, Grant DR, Vollmer CM Jr (2007) Impact of regional lymph node evaluation in staging patients with periampullary tumors. Ann Surg Oncol 14:202–210PubMedCrossRefGoogle Scholar
  46. Manfredi R, Costamagna G, Brizi MG, Maresca G, Vecchioli A, Colagrande C, Marano P (2000) Severe chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation. Radiology 214:849–855PubMedCrossRefGoogle Scholar
  47. Matos C, Cappeliez O, Winant C, Coppens E, Devière J, Metens T (2002) MR imaging of the pancreas: a pictorial tour. Radiographics 22:e2PubMedCrossRefGoogle Scholar
  48. Matsuki M, Inada Y, Nakai G, Tatsugami F, Tanikake M, Narabayashi I, Masuda D, Arisaka Y, Takaori K, Tanigawa N (2007). Diffusion-weighed MR imaging of pancreatic carcinoma. Abdom Imaging. 32: 481–3PubMedCrossRefGoogle Scholar
  49. Michl P, Pauls S, Gress TM (2006) Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol 20:227–251PubMedCrossRefGoogle Scholar
  50. Miller FH, Rini NJ, Keppke AL (2006) MRI of adenocarcinoma of the pancreas. AJR Am J Roentgenol 187:W365–W374PubMedCrossRefGoogle Scholar
  51. Morana G, Tapparelli M, Faccioli N, D’Onofrio M, Pozzi Mucelli R (2005) Autoimmune pancreatitis: instrumental diagnosis. JOP 13(6):102–107Google Scholar
  52. Mori H, Miyake H, Aikawa H, Monzen Y, Maeda T, Suzuki K, Matsumoto S, Wakisaka M (1991) Dilated posterior superior pancreaticoduodenal vein: recognition with CT and clinical significance in patients with pancreaticobiliary carcinomas. Radiology 181:793–800PubMedGoogle Scholar
  53. Mueller GC, Hussain HK, Carlos RC, Nghiem HV, Francis IR (2003) Effectiveness of MR imaging in characterizing small hepatic lesions: routine versus expert interpretation. AJR Am J Roentgenol 180:673–680PubMedCrossRefGoogle Scholar
  54. O’Malley ME, Boland GW, Wood BJ, Fernandez-del Castillo C, Warshaw AL, Mueller PR (1999) Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol 173(6):1513–1518PubMedCrossRefGoogle Scholar
  55. Okazaki K, Chiba T (2002) Autoimmune related pancreatitis. Gut 51:1–4PubMedCentralPubMedCrossRefGoogle Scholar
  56. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PI, Borel Rinkes IH, Wiggers T (1997) Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 203:449–456PubMedGoogle Scholar
  57. Pamuklar E, Semelka RC (2005) MR imaging of the pancreas. Magn Reson Imaging Clin N Am 13:313–330PubMedCrossRefGoogle Scholar
  58. Pancreatic Cancer Registration Committee in Japan Pancreas Society (2003) Pancreatic cancer registration of JPS: the summary for 20 years. J Jpn Pancreas Soc 18:101–169Google Scholar
  59. Pearson RK, Longnecker DS, Chari ST, Smyrk TC, Okazaki K, Frulloni L, Cavallini G (2003) Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 27:1–13PubMedCrossRefGoogle Scholar
  60. Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R et al (2000) Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging – a multicenter phase III clinical study. Radiology 215:727–736PubMedCrossRefGoogle Scholar
  61. Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B et al (1997) Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 7:275–280PubMedCrossRefGoogle Scholar
  62. Robinson PJ, Arnold P, Wilson D (2003) Small “indeterminate” lesions on CT of the liver: a follow-up study of stability. Br J Radiol 76:866–874PubMedCrossRefGoogle Scholar
  63. Roche CJ, Hughes ML, Garvey CJ, Campbell F, White DA, Jones L, Neoptolemos JP (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 180:475–480PubMedCrossRefGoogle Scholar
  64. Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, Lauwers GY, Fernandez CD, Warshaw AL, Simeone JF (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345–352PubMedCrossRefGoogle Scholar
  65. Sahani DV, Shah ZK, Catalano OA, Boland GW, Brugge WR (2008) Radiology of pancreatic adenocarcinoma: current status of imaging. J Gastroenterol Hepatol 23:23–33PubMedCrossRefGoogle Scholar
  66. Sai M, Mori H, Kiyonaga M, Kosen K, Yamada Y, Matsumoto S (2010). Peripancreatic lymphatic invasion by pancreatic carcinoma: evaluation with multi-detector row CT. Abdom Imaging. 35: 154–62Google Scholar
  67. Schima W, Függer R (2002) Evaluation of focal pancreatic masses: comparison of mangafodipir-enhanced MR imaging and contrast-enhanced helical CT. Eur Radiol 12:2998–3008PubMedGoogle Scholar
  68. Schima W, Ba-Ssalamah A, Kölblinger C, Kulinna-Cosentini C, Puespoek A, Götzinger P (2007) Pancreatic adenocarcinoma. Eur Radiol 17:638–649PubMedCrossRefGoogle Scholar
  69. Schneider AR, Adamek HE, Layer G, Riemann JF, Arnold JC (2003) Staging of abdominal metastases in pancreatic carcinoma by diagnostic laparoscopy and magnetic resonance imaging. Z Gastroenterol 41:697–702PubMedCrossRefGoogle Scholar
  70. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210:71–74PubMedCrossRefGoogle Scholar
  71. Seiki M, Katsusuke S, Makoto S, Go, Vay Liang WG (2004) Advancements in pancreatic cancer research in Japan and unfolding prospective. Pancreas 28:217–218Google Scholar
  72. Semelka RC, Hussain SM, Marcos HB, Woosley JT (1999) Biliary hamartomas: solitary and multiple lesions shown on current MR techniques including gadolinium enhancement. J Magn Reson Imaging 10(2):196–201PubMedCrossRefGoogle Scholar
  73. Seneterre E, Taourel P, Bouvier Y, Pradel J, Van Beers B, Daures JP et al (1996) Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200:785–792PubMedGoogle Scholar
  74. Sobin LH, Wittekind C (2002) TNM classification of malignant tumors (International Union Against Cancer), 6th edn. Wiley-Liss, New YorkGoogle Scholar
  75. Stolte M, Weiss W, Volkholz H, Rösch W (1982) A special form of segmental pancreatitis: “groove pancreatitis”. Hepatogastroenterology 29:198–208PubMedGoogle Scholar
  76. Tajima Y, Kuroki T, Tsutsumi R, Isomoto I, Uetani M, Kanematsu T (2007) Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 14(13):858–865Google Scholar
  77. Takahashi S, Kim T, Murakami T, Okada A, Hori M, Narumi Y, Nakamura H (2000). Influence of paramagnetic contrast on single-shot MRCP image quality. Abdom Imaging. 25: 511–3PubMedCrossRefGoogle Scholar
  78. Takayama M, Hamano H, Ochi Y, Saegusa H, Komatsu K, Muraki T, Arakura N, Imai Y, Hasebe O, Kawa S (2004) Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 99:932–937PubMedCrossRefGoogle Scholar
  79. Takeuchi M, Matsuzaki K, Kubo H, Nishitani H (2008) High-b-value diffusion-weighted magnetic resonance imaging of pancreatic cancer and mass-forming chronic pancreatitis: preliminary results. Acta Radiol 49:383–386PubMedCrossRefGoogle Scholar
  80. Tamm EP, Silverman PM, Charnsangavej C, Evans DB (2003) Diagnosis, staging, and surveillance of pancreatic cancer. Am J Roentgenol 20(180):1311–1323CrossRefGoogle Scholar
  81. Taniguchi T, Kobayashi H, Nishikawa K, Iida E, Michigami Y, Morimoto E, Yamashita R, Miyagi K, Okamoto M (2009) Diffusion-weighted magnetic resonance imaging in autoimmune pancreatitis. Jpn J Radiol 27(3):138–142PubMedCrossRefGoogle Scholar
  82. Tien YW, Wu YM, Lin WC, Lee HS, Lee PH (2009) Pancreatic carcinoma cells stimulate proliferation and matrix synthesis of hepatic stellate cells. Hepatology 51:307–314CrossRefGoogle Scholar
  83. To’o KJ, Raman SS, Yu NC, Kim YJ, Crawford T, Kadell BM, Lu DS (2005) Pancreatic and peripancreatic diseases mimicking primary pancreatic neoplasia. Radiographics 25:949–965PubMedCrossRefGoogle Scholar
  84. Tsushima Y, Takano A, Taketomi-Takahashi A, Endo K (2007) Body diffusion-weighted MR imaging using high b-value for malignant tumor screening: usefulness and necessity of referring to T2-weighted images and creating fusion images. Acad Radiol 14:643–650PubMedCrossRefGoogle Scholar
  85. Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Okai T, Sawabu N (2003) Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma. Am J Gastroenterol 98:2679–2687PubMedCrossRefGoogle Scholar
  86. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ (1999) Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210:459–466PubMedCrossRefGoogle Scholar
  87. Wolff RA, Chiao P, Lenzi R, Pisters PW, Lee JE, Janjan NA et al (2000) Current approaches and future strategies for pancreatic carcinoma. Invest New Drugs 18:43–56PubMedCrossRefGoogle Scholar
  88. Wray CJ, Ahmad SA, Matthews JB, Lowy AM (2005) Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 128:1626–1641PubMedCrossRefGoogle Scholar
  89. Yamada Y, Mori H, Kiyosue H, Matsumoto S, Hori Y, Maeda T (2000) CT assessment of the inferior peripancreatic veins: clinical significance. AJR Am J Roentgenol 174:677–684PubMedCrossRefGoogle Scholar
  90. Zhang J, Israel GM, Hecht EM, Krinsky GA, Babb JS, Lee VS (2006) Isotropic 3D T2-weighted MR cholangiopancreatography with parallel imaging: feasibility study. AJR Am J Roentgenol 187:1564–1570PubMedCrossRefGoogle Scholar
  91. Zhong L, Li L, Yao QY (2005) Preoperative evaluation of pancreaticobiliary tumor using MR multi-imaging techniques. World J Gastroenterol 11(24):3756–3761PubMedGoogle Scholar
  92. Zhong L et al (2007) Magnetic resonance imaging in the detection of pancreatic neoplasm. J Dig Dis 8:128–132PubMedCrossRefGoogle Scholar
  93. Zins M, Petit E, Boulay-Coletta I, Balaton A, Marty O, Berrod JL (2005) Imaging of pancreatic adenocarcinoma. J Radiol 86:759–779PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Giovanni Morana
    • 1
  • Raffaella Pozzi Mucelli
    • 1
  • Giuseppe Granieri
    • 1
  • Christian Cugini
    • 1
  1. 1.Radiological DepartmentGeneral Hospital Ca’ FoncelloTrevisoItaly

Personalised recommendations